Schedule 13G ownership disclosure
Whitehawk Therapeutics, Inc.
Security class unavailable · CUSIP: 00032Q104
Event date: 2024-08-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,845,253
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000579
- Form type
- SC 13G
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Sep 03, 2024
- Reporting period
- Aug 23, 2024
- Description
- Schedule 13G beneficial ownership